Antibody-mediated crosslinking of Thy-1 [also known as cluster of differentiation (CD)90], results in a T cell receptor (TcR)-like signal; however, the impact of Thy-1 stimulation in comparison to TcR stimulation on T cell activation and effector function has yet to be fully elucidated. In the present study, the outcome of Thy-1-and TcR-induced stimulation of T cells was investigated in mice, using fragment crystalizable (Fc) receptor-bound antibodies and costimulatory signals provided by syngeneic lipopolysaccharide-matured bone marrow-derived dendritic cells. Compared with TcR signaling, Thy-1 signaling initiated a less robust proliferative response in T cells, as determined by tritiated-thymidine incorporation. In addition, enzyme-linked immunosorbent assays revealed that interleukin-2 production was reduced, and the expression of CD25 and cyclin D3 was weaker in Thy-1-stimulated cells, as determined by western blotting; however, the expression of cyclin-dependent kinase 6 was similar to that in TcR-induced T cells. Furthermore, western blotting demonstrated that the phosphorylation of ζ-chain-associated protein kinase 70 and extracellular signal-regulated kinase 1/2 was delayed following Thy-1 stimulation. DNA fragmentation assays revealed that cytotoxic effector function was also slower to develop in Thy-1-stimulated T cells, required more time to be effective and was largely Ca 2+ -independent; these findings suggested that Fas ligand rather than granule-associated perforin was involved in T cell effector function. In conclusion, the present results suggested that Thy-1 signaling may contribute to the regulation of T cell homeostasis and the development of non-specific T cell-mediated cytotoxicity. However, further studies are required to elucidate the exact physiological roles of TcR-like signals that result from Thy-1 crosslinking and to investigate the molecular mechanisms that are involved.
Introduction
Thy-1 [also known as cluster of differentiation (CD)90] is a 25 kDa glycosylphosphatidylinositol (GPI)-anchored cell surface protein that is involved in numerous biological processes, including T cell activation and apoptosis, wound healing and tumor suppression (1) (2) (3) . Thy-1 is abundantly expressed on mouse thymocytes and peripheral T cells (4); however, the exact roles of Thy-1 in mouse T cell function have yet to be elucidated (1) (2) (3) . Paradoxically, Thy-1 signaling has been reported to exert stimulatory and suppressive effects on murine T cells; for example, thymocytes from Thy-1-deficient mice appeared to be hyper-responsive to T cell receptor (TcR) stimulation (4) , which suggested that Thy-1 may inhibit TcR signaling under certain circumstances. In addition, CD4 + mouse T cells that were stimulated by Thy-1 in the absence of costimulatory signals acquired a T regulatory cell-like phenotype (5) , which suggested a role for Thy-1 in the maintenance of T cell homeostasis. Conversely, TcR-driven proliferation of peripheral T cells was suppressed in Thy-1-deficient mice (6) , whereas Thy-1 inhibition interfered with the induction of non-specific cytotoxic T cells mediated by anti-CD3 monoclonal antibodies (7) . These data suggested that Thy-1 may potentiate TcR signaling, possibly through enhanced phosphorylation of the raft-associated adaptor protein linker for activation of T cells (8) . In addition, the activation of Thy-1 in the presence of costimulatory signals provided by syngeneic dendritic cells was previously reported to result in T cell proliferation, interleukin (IL)-2 production and high-affinity IL-2 receptor subunit α (also known as CD25) expression (7) , consistent with the role of Thy-1 in providing a non-specific TcR-like stimulatory signal. Similar to TcR signaling, Thy-1 stimulation of T cells in the context of costimulation by dendritic cells promotes the expression of cytotoxic effector molecules, including perforin, granzyme B and Fas ligand; however, unlike TcR signaling, Thy-1 stimulation did not induce detectable cytotoxicity in a 4 h redirected lysis assay (7) .
The molecular mechanism by which GPI-anchored proteins such as Thy-1, which lack cytoplasmic domains, transmit signals to the T cell nucleus from the extracellular environment is yet to be elucidated. Thy-1 crosslinking has previously been reported to activate a TcR-like signal transduction pathway that involves intracellular Ca 2+ flux (9) , and the activation of signaling molecules, including protein tyrosine kinases, calcineurin, phospholipase Cγ, protein kinase C, phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K), and mitogen-activated protein kinases (MAPKs) (10, 11) . Thy-1-induced T cell activation was demonstrated to require the coexpression of the TcR/CD3 complex (12) , which indicated a potential role for TcR-associated signal transduction pathways in Thy-1 signaling. However, Thy-1 stimulation was previously demonstrated to induce Ca 2+ flux and other signaling events in Thy-1-transfected B cells that lack TcR (9) , which indicated the association of highly conserved signaling molecules with Thy-1. Notably, Thy-1 is able to interact, via phosphorylated (p)-p85-90, with the protein tyrosine kinases Fyn and lymphocyte-specific protein tyrosine kinase (Lck), PI3K, C-terminal Src kinase, the GTPase-activating protein Ras, Vav and the tyrosine phosphatase CD45 (13) (14) (15) (16) . As Thy-1 co-localizes with protein tyrosine kinases and other signaling molecules, it may be hypothesized that antibody-mediated crosslinking of Thy-1, within plasma membrane microdomains, may lead to T cell activation by promoting lipid raft aggregation, similar to the mechanisms previously reported for other GPI-anchored proteins that are expressed by lymphocytes and hematopoietic cells (17) .
Functional outcomes of the activation of cell-surface receptors and their associated signal-transduction pathways are dictated by signal strength and kinetics. For example, the decision between CD4 + and CD8 + lineage commitment during thymocyte development depends on the strength and duration of intracellular Ca 2+ flux and extracellular signal-regulated kinase (ERK)-mediated signaling induced by TcR activation (18) . The strength of the TcR signal also influences the development of various T helper cell subsets (19, 20) , the expression of homing receptors that guide T cell migration (21) , and the effector function of cytotoxic T lymphocytes (22, 23) . However, the consequences of T cell activation by Thy-1 have yet to be fully elucidated. Therefore, the aim of the present study was to investigate the effects of Thy-1 stimulation, in the context of costimulation provided by syngeneic bone marrow-derived dendritic cells (BMDCs), on the activation and subsequent effector function of T cells, compared with TcR crosslinking.
Materials and methods

Animals.
A total of 90 female C57BL/6 mice (age, 6-8 weeks; weight, 20-24 g) were purchased from Charles River Laboratories, Inc. (Wilmington, MA, USA) and housed at 21˚C and 50% humidity with a 12-h light/dark cycle in the Carleton Animal Care Facility at Dalhousie University (Halifax, Canada). Mice were maintained on standard rodent chow and water, which was supplied ad libitum. Animal protocols were consistent with the guidelines of the Canadian Council on Animal Care (www.ccac.ca) and were approved by the Dalhousie University Committee on Laboratory Animals.
Cell lines. Mouse P815 mastocytoma cells were obtained from American Type Culture Collection (ATCC; Manassas, VA, USA). Cells were cultured in RPMI-1640 medium (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) supplemented with 5% heat-inactivated fetal calf serum (FCS), 100 U/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine and 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (all purchased from Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA), and maintained at 37˚C in a humidified 5% CO 2 atmosphere.
Cytokines and antibodies. Recombinant mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-2 were purchased from R&D Systems, Inc. (Minneapolis, MN, USA). Functional grade (FG) purified rat anti-Thy-1 immunoglobulin (Ig)G2c (clone G7, cat. no. 553015) monoclonal antibody (mAb) and FG purified rat IgG2c isotype control (cat. no. 553981) were purchased from BD Biosciences (Franklin Lakes, NJ, USA). FG purified hamster anti-TcRβ IgG mAb (clone H57-597, cat. no. 5013368), FG purified hamster IgG isotype control (cat. no. 16-4888-81), fluorescein isothiocyanate (FITC)-conjugated hamster anti-CD3e IgG mAb (clone 145-2C11, cat. no. 11-0031-82), FITC-conjugated hamster anti-CD11c IgG mAb (clone N418, cat. no. 11-0114-82), FITC-conjugated hamster anti-CD80 IgG mAb (clone 16-10A1, cat. no. 17-0801-82), FITC-conjugated rat anti-CD86 IgG2a mAb (clone GL1, cat. no. 11-0862-82), FITC-conjugated rat anti-MHC Class II (I-A/I-E) IgG2b mAb (clone M5/114.15.2, cat. no. 11-5321-82), and FITC-conjugated rat IgG1 (cat. no. 11-4812-82) were purchased from eBioscience (Thermo Fisher Scientific, Inc.). FITC-conjugated rat anti-CD25 IgG1 (clone PC61.5.3, cat. no. CL8925F) was purchased from Cedarlane Laboratories (Burlington, ON, Canada). Anti-survivin (clone 71G4B7, rabbit IgG, cat. no. 2808), anti-cyclin-dependent kinase 6 (CDK6) (clone DCS83, mouse IgG1, cat. no. 3136S), anti-cyclin D3 (clone DCS22, mouse IgG1, cat. no. 2936S), anti-ζ-chain-associated protein kinase (ZAP)-70 (clone 99F2, rabbit IgG, cat. no. 2705S) and anti-p-ZAP-70 (Tyr319, polyclonal rabbit IgG, cat. no. 2701S) primary antibodies were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Anti-β-actin (polyclonal goat IgG, cat. no. sc-1616), anti-p-ERK1/2 (clone E-4, mouse IgG2a, cat. no. sc-7383), anti-ERK1/2 (polyclonal rabbit IgG, cat. no. sc-153), anti-CD25 (polyclonal rabbit IgG, cat. no. sc-666) primary antibodies, and the secondary antibodies horseradish peroxidase (HRP)-conjugated bovine anti-goat IgG (cat. no. sc-2378), HRP-conjugated donkey anti-rabbit IgG (cat. no. sc-2313), and HRP-conjugated goat anti-mouse IgG (cat. no. sc-2005) were obtained from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA).
T cell isolation. Mice were sacrificed, spleens were removed and a single cell suspension was prepared in phosphate-buffered saline (PBS, pH 7.2) at 4˚C using a hand-held tissue homogenizer. Erythrocytes were depleted by hypotonic shock. Briefly, spleen cells were resuspended at room temperature in sterile 0.2% saline followed by an equal volume of sterile 1.6% saline following 20 sec. Magnetic-activated cell sorting was used for CD3 + T cell isolation by negative selection with the Pan T Cell Isolation MACS kit (Miltenyi Biotec, Inc., San Diego, CA, USA), according to the manufacturer's instructions. Isolated T cells were >98% pure, as determined by assessing CD3 expression using flow cytometry, as described in the following Flow cytometry subsection.
BMDC generation. BMDCs were obtained as previously described with slight modifications (24) . Briefly, C57BL/6 mice were sacrificed and bone marrow was flushed from the tibiae and femurs with PBS under aseptic conditions. Erythrocytes were depleted from the bone marrow preparations by hypotonic shock, as aforementioned. Bone marrow cells (1x10 6 cells/well) were resuspended and cultured at 37˚C in a humidified 5% CO 2 atmosphere in 6-well tissue culture plates (Sarstedt AG & Co., Nümbrecht, Germany) containing BMDC medium (RPMI-1640 medium supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, 200 U/ml penicillin, 200 µg/ml streptomycin, 5 mM HEPES buffer, 50 µM β-mercaptoethanol and 20 ng/ml GM-CSF). The medium was replaced every 3 days. On day 8, non-adherent cells were collected using a pipette and transferred to new culture plates with fresh BMDC medium. BMDCs were matured by culture at 37˚C in a humidified 5% CO 2 atmosphere in the presence of 1 µg/ml lipopolysaccharide (LPS; Sigma-Aldrich; Merck KGaA) on day 8 or 9, and then harvested with a cell scraper following 24 h for use in experiments on day 9 or 10, respectively. BMDCs were determined to by >80% pure by assessing CD11c, major histocompatibility complex class II, CD80 and CD86 expression using flow cytometry, as described in the following Flow cytometry subsection.
T cell activation. T cells (2.5x10 4 cells/well) were seeded in 96-well round-bottom plates (Sarstedt AG & Co.) and activated with or without LPS-matured syngeneic BMDCs (8,000 cells/well), with anti-Thy-1 mAb, anti-TcRβ mAb or the appropriate isotype control at a final concentration of 6 µg/ml (1:167 dilution, unless otherwise specified), by culture at 37˚C in a humidified 5% CO 2 atmosphere for 24, 48, 72 and/or 96 h, depending on the nature of the experiment. This ratio of T cells to BMDCs has been reported to promote optimal anti-Thy-1 mAb-mediated T cell proliferation, following Thy-1 crosslinking by fragment crystalizable (Fc) receptor-bound Ab together with costimulatory signaling (25) . For flow cytometry, western blotting, IL-2 measurements and cytotoxicity assays, T cells (1.25-2.5x10 6 cells/well) were seeded in 24-well flat-bottom plates (Sarstedt AG & Co.) and activated with or without LPS-matured syngeneic BMDCs (4-8x10 4 cells/well) and anti-Thy-1 mAb, anti-TcRβ mAb, or the appropriate isotype control, at a final concentration of 6 µg/ml (1:167 dilution), then cultured at 37˚C in a humidified 5% CO 2 atmosphere for 5, 10, 60, 120, 240 and/or 480 min, or 12, 24, 48 and/or 72 h, depending on the nature of the experiment. T cells were cultured in RPMI-1640 medium (Sigma-Aldrich; Merck KGaA) supplemented with 5% heat-inactivated FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine and 5 mM HEPES buffer, and maintained at 37˚C in a humidified 5% CO 2 atmosphere.
T cell proliferation assay. T cells (2.5x10 4 cells/well) were plated in 96-well round-bottomed plates and cultured in the presence of anti-Thy-1 mAb, anti-TcRβ mAb or the appropriate isotype control as aforementioned for 24-96 h. They were pulsed with 0.25 µCi of tritiated thymidine ([ 3 H]-TdR; MP Biomedicals LLC, Santa Ana, CA, USA) during the final 6 h of culture. To determine whether exogenous IL-2 would induce T cell proliferation in response to Thy-1 stimulation, anti-Thy-1 mAb was combined with 100 U/ml recombinant mouse IL-2 or the vehicle. [ 3 H]-TdR-labeled DNA was harvested onto glass fiber filter mats using a Titertek Cell Harvester (Skatron, Sterling, VA, USA), then radioactivity was determined using a Beckman LS6000IC liquid scintillation counter (Beckman Coulter, Inc., Brea, CA, USA). Data were analyzed using Microsoft Office Excel's Analysis ToolPak (Microsoft Corporation, Redmond, WA, USA).
Western blot analysis. Cells (1.25x10 6 cells/ml) were washed once with ice-cold PBS, centrifuged at 500 x g for 5 min at 4˚C, and then lysed with ice-cold lysis buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 50 mM Na 2 HPO 4 , 0.25% sodium deoxycholate (w/v), 0.1% Nonidet P-40 (v/v), 5 mM EDTA and 5 mM EGTA], supplemented with fresh protease and phosphatase inhibitors (100 µM Na 3 VO 4 , 10 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, 10 µM phenylarsine oxide, 1 mM dithiothreitol, 5 µg/ml leupeptin and 5 µg/ml pepstatin) for 30 min on ice. Cellular debris was removed from the lysates by centrifugation at 10,000 x g for 10 min at 4˚C. Total protein concentration in the lysates was determined using a Bradford Assay kit (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Samples were diluted with SDS-PAGE sample buffer [containing 200 mM Tris-HCl (pH 6.8)
Lysates were heated at 90-100˚C for 5 min to promote denaturation and stored at -80˚C until used. Equal amounts of extracted protein samples (10-20 µg) were separated on Tris-HCl acrylamide resolving gels and transferred onto nitrocellulose membranes using the iBlot Dry Blotting system (Invitrogen; Thermo Fisher Scientific, Inc.). Membranes were washed once in TBS containing 0.05% Tween-20 (TBST), and blocked in TBST containing 5% fat-free milk powder (w/v) for 1 h at room temperature or overnight at 4˚C with gentle agitation. Membranes were washed 3 times with TBST and incubated with the primary antibodies (anti-β-actin, anti-CD25, anti-CDK6, anti-cyclin D3, anti-ERK1/2, anti-p-ERK1/2, anti-survivin, anti-ZAP-70, or anti-p-ZAP-70 mAb), all at a 1:500 working dilution in TBST containing 5% fat-free milk powder (w/v), for 1 h at room temperature or overnight at 4˚C with gentle agitation. Membranes were washed with TBST and then incubated with the HRP-conjugated secondary polyclonal antibodies (bovine anti-goat IgG for anti-β-actin; donkey anti-rabbit IgG for anti-CD25, anti-ERK1/2, anti-survivin, anti-ZAP-70 and anti-p-ZAP-70; goat anti-mouse for anti-CDK6, anti-cyclin D3 and anti-p-ERK1/2), all at a 1:1,000 working dilution in TBST containing 5% fat-free milk powder (w/v), for 1 h at room temperature with gentle agitation. Membranes were washed with TBST and protein bands were visualized using enhanced chemiluminescence (ECL) or ECL Plus reagents (GE Healthcare Life Sciences, Little Chalfont, UK). Excess reagent was removed and membranes were exposed to X-ray film in the dark; X-ray film was developed using a Kodak X-OMAT 1000A processor (Kodak, Rochester, NY, USA). ImageJ software (version 1.45; National Institutes of Health, Bethesda, MD, USA) was used for densitometric analysis. Protein expression was normalized to β-actin.
Flow cytometry. Cells (1.25x10 6 cells/ml) were cultured for 48 h in the presence of 6 µg/ml anti-Thy-1 mAb or anti-TcRβ mAb, as aforementioned. Cells were then washed in cold fluorescence-activated cell sorting (FACS) buffer containing 1% bovine serum albumin (w/v, Sigma-Aldrich; Merck KGaA) and 0.2% sodium azide (w/v) in PBS. Cells were then incubated with a 1:100 dilution of FITC-conjugated anti-CD25 mAb or the appropriate isotype control. Cells were incubated on ice in the dark for 45 min, washed 3 times with cold FACS buffer and resuspended in fixative solution (1% paraformaldehyde in PBS) at room temperature and immediately stored overnight in the dark at 4˚C prior to analysis using a BD FACSCalibur flow cytometer with BD CellQuest software version 3.3 (BD Biosciences), and the resulting data were analyzed using FCS Express software version 3.0 (De Novo Software, Glendale, CA, USA).
Cytokine measurement. IL-2 expression levels in T cell culture supernatants were measured using an IL-2 enzyme-linked immunosorbent assay kit (ELISA, cat. no. 555148; BD Biosciences), according to the manufacturer's instructions. Absorbance was measured at 450 nm with a wavelength correction for 570 nm using an ELx800 microplate reader and KCjunior software version 1.17 (both from BioTek Instruments, Inc., Winooski, VT, USA). SoftMax Pro software version 4.3 (Molecular Devices, LLC, Sunnyvale, CA, USA) was used to determine cytokine concentrations from the absorbance readings.
T cell-mediated cytotoxicity assay. A DNA fragmentation assay was used to measure cytotoxic effector function, as previously described (26) . Briefly, P815 target cells (5x10 6 ), which are sensitive to anti-CD3 mAb-redirected lysis (7) , were resuspended in [ 3 H]-TdR (5 µCi/ml) and radiolabeled by incubation for 4 h at 37˚C in a humidified 5% CO 2 atmosphere, and subsequently washed and resuspended in RPMI-1640 medium supplemented with 5% heat-inactivated FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine and 5 mM HEPES buffer. P815 cells (5x10 4 cells/well) were added in quadruplicate to 96-well round-bottom tissue culture plates and co-cultured at a ratio of 1:50 with resting T cells, T cells that had been activated with 6 µg/ml anti-Thy-1 mAb-or anti-TcR mAb for 4, 18, or 24 h, or with LPS-matured B cells (negative control) for 4 or 24 h at 37˚C in a humidified 5% CO 2 atmosphere. To determine whether cytotoxicity was Ca 2+ -dependent or Ca 2+ -independent, radiolabeled P815 cells and T cells that had been activated with 6 µg/ml anti-Thy-1 mAb-or anti-TcR mAb for 24 h were combined at a ratio of 1:50 and incubated for 4 or 24 h with medium alone, vehicle (PBS), or 4 mM EGTA and 2 mM MgCl 2 to prevent Ca 2+ -dependent granule-mediated cytotoxicity (27) . Radiolabeled DNA was harvested onto glass fiber filter mats using the Titertek Cell Harvester (Skatron) and radioactivity was then measured (counts/min; cpm) using liquid scintillation counting, as aforementioned. The percentage of DNA fragmentation of P815 target cells was calculated according to the following formula: DNA fragmentation (%) = 1-[(C cpm -E cpm )/C cpm ], where E is intact DNA from P815 target cells co-cultured with effector cells and C is intact DNA from P815 target cells alone.
Statistical analysis. Data are expressed as either the mean ± standard deviation or the mean ± standard error of the mean of 3 independent experiments. The statistical significance of the differences between groups was determined using Student's t-test for pair-wise comparisons or one-way analysis of variance with a Bonferroni post hoc test for multiple comparisons (InStat v2.04a GraphPad Software; GraphPad Software, Inc., La Jolla, CA, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
Induction of DNA synthesis is weaker following Thy-1 signaling compared with TcR signaling. DNA synthesis induced by Thy-1 or TcRβ mAb crosslinking, in the presence of syngeneic BMDCs as a source of costimulation, was investigated using a [ 3 H]-TdR incorporation assay. Thy-1 stimulation appeared to be a less potent inducer of DNA synthesis compared with TcRβ stimulation at the various mAb concentrations tested (Fig. 1A) , which indicated that the Thy-1-associated signal is weaker compared with the signal generated by TcRβ crosslinking. Subsequent experiments used anti-Thy-1 mAb and anti-TcRβ mAb at a final concentration of 6 µg/ml, as this was in excess of the concentration needed to achieve a maximum response. The kinetics of DNA synthesis induced by Thy-1 and TcRβ crosslinking were similar, both reaching a peak following 72 h of culture despite Thy-1 stimulation being weaker than TcRβ stimulation (Fig. 1B) .
The effects of Thy-1 and TcR signaling on T cell transition from the quiescent G 0 state into the G 1 phase of the cell cycle, which involves CDK4 and CDK6 activation by D-type cyclins (28) , were also explored. The expression of cyclin D3, which activates CDK6, was significantly decreased in anti-Thy-1 mAb-stimulated T cells compared with in anti-TcRβ mAb-stimulated T cells at 48 h, however, in both cases cyclin D3 expression peaked at 48 h ( Fig. 2A) . Notably, no significant differences were identified for the expression of CDK6 with either of the activating conditions; however, in both instances CDK6 expression peaked at 24-48 h (Fig. 2B ). These findings suggested that an alternative pathway of CDK6 activation may be stimulated in anti-Thy-1 mAb-induced T cells. In addition, the expression of the antiapoptotic protein survivin, as determined by western blot analysis, was also similar in T cells following Thy-1-and TcRβ-mediated stimulation (data not shown).
Induction of CD25 and IL-2 production is weaker following
Thy-1 stimulation compared with TcRβ. Western blot analysis revealed that CD25 expression in T cells was significantly lower at 24 and 48 h following Thy-1 mAb crosslinking compared with TcRβ crosslinking in the presence of syngeneic BMDCs (Fig. 3) . The detection of CD25 as multiple protein bands at ~55 kDa may possibly be attributed to heterogeneous post-translational modifications at multiple N-and O-glycosylation sites of the protein molecule (29) . Similar results were obtained following the detection of cell-surface CD25 on anti-Thy-1-and anti-TcRβ-stimulated T cells using flow cytometry. Following 48 h of culture, the mean fluorescence intensity (in channel fluorescence units) of cells stained with FITC-conjugated anti-CD25 mAb was 47±2 for TcR stimulation, and 21±2 for Thy-1 stimulation (P<0.01; data not presented).
In addition, ELISA analysis demonstrated that in T cells stimulated with anti-Thy-1 mAb the production of IL-2 was significantly less compared with IL-2 production in anti-TcRβ mAb-stimulated T cells (Fig. 4) . However, the addition of 100 U/ml recombinant mouse IL-2 to anti-Thy-1 mAb-stimulated T cell cultures did not appear to enhance DNA synthesis (data not shown).
Thy-1-induced ZAP-70 and ERK1/2 phosphorylation is delayed compared with TcR-induced phosphorylation.
The ability of anti-Thy-1 mAb and anti-TcRβ mAb crosslinking to induce phosphorylation of the ZAP-70 tyrosine kinase and ERK1/2 MAPK in T cells was investigated in the presence of syngeneic BMDCs. As presented in Fig. 5A , the phosphorylation of ZAP-70 at Tyr319 was increased 5 min following T cell activation with anti-TcRβ mAb and remained elevated relative to the 0 min control at all subsequent time-points; conversely, following Thy-1-induced stimulation, ZAP-70 phosphorylation was not detected until the 120 min time-point and remained elevated relative to the 0 min control at the 240 min time-point. Similarly, Fig. 5B reveals that ERK1 and ERK2 phosphorylation was not detected until 60 min following Thy-1 stimulation and remained elevated at all later time-points. By contrast, ERK1 and ERK2 phosphorylation in response to TcR crosslinking was increased at the 5 min time-point, peaked at 60 min and declined thereafter.
Thy-1 stimulation induces Fas ligand-mediated cytotoxicity with delayed kinetics compared with TcR stimulation.
The delayed kinetics of ZAP-70 and ERK1/2 phosphorylation following Thy-1 stimulation of T cells led to the hypothesis that the acquisition of cytotoxic effector function may also be delayed in Thy-1-stimulated T cells. Therefore, T cells were initially activated with anti-Thy-1 or anti-TcRβ mAb in the presence of LPS-matured BMDCs for 4, 18 and 24 h. The cytotoxic potential of anti-Thy-1-activated and anti-TcRβ-activated T cells against Fc receptor-bearing P815 target cells was then assessed by redirected lysis using 4 and 24 h DNA fragmentation assays. In the 4 h DNA fragmentation assay, anti-TcRβ mAb-activated T cells exhibited cytotoxicity as early as 18 h following initial stimulation (Fig. 6A ). However, in the 24 h DNA fragmentation assay, anti-TcRβ mAb-activated T cells exhibited cytotoxicity 4 h following their stimulation (Fig. 6B ). By contrast, T cells that were stimulated with anti-Thy-1 mAb for as long as 24 h failed to exhibit cytotoxicity in a 4 h DNA fragmentation assay (Fig. 6A) ; however, cytotoxic activity was observed when anti-TcRβ mAb was added to the DNA fragmentation assay, indicating that the T cells retained the ability to respond to TcR stimulation (Fig. 6A) . Notably, Thy-1 stimulation over 18-24 h was able to induce cytotoxic effector function in a 24 h DNA fragmentation assay, however, Thy-1 stimulation for 24 h was required to achieve cytotoxic activity that was similar to that of TcR-stimulated T cells (Fig. 6B ). The addition of anti-TcRβ mAb to the 24 h DNA fragmentation assay increased the cytotoxic activity of T cells that were activated with anti-Thy-1 mAb for 4 or 18 h, however, not following 24 h (Fig. 6B) . No significant DNA fragmentation was identified at any time-point using LPS-stimulated B cells as a negative control ( Fig. 6A and B ). In addition, cytotoxic T lymphocytes induced by TcRβ crosslinking demonstrated a significant reduction in effector function in 4 h DNA fragmentation assays performed in the presence of EGTA/MgCl 2 to chelate extracellular Ca 2+ (Fig. 7A) , which differentiates between Ca 2+ -dependent granule-mediated cytotoxicity and Ca 2+ -independent cytotoxicity mediated by Fas/Fas ligand interactions (27) . Thus, in a 4 h DNA fragmentation assay, anti-TcRβ-activated T cells rely primarily upon Ca 2+ -dependent granule-mediated cytotoxicity to kill target cells. Conversely, EGTA/MgCl 2 had little effect on the cytotoxic effector function of anti-TcRβ-activated T cells in 24-h DNA fragmentation assays, indicating a major role for a Ca 2+ -independent cytotoxic mechanism (Fig. 7B) . Anti-Thy-1-activated T cells did not exhibit Ca 2+ -dependent or -independent cytotoxic activity in the 4 h DNA fragmentation. In the 24 h DNA fragmentation assay, the cytotoxic activity of anti-Thy-1-activated T cells was not affected by EGTA/MgCl 2 , indicating that cytotoxicity was Ca 2+independent. These findings indicated that a longer duration of Thy-1 signaling may be required for T cells to acquire Ca 2+ -independent cytotoxic effector function, which accounts for all of their cytotoxic activity. . Thy-1 signaling is a less potent inducer of IL-2 production compared with TcR signaling. T cells with or without lipopolysaccharide-matured BMDCs were cultured in the presence or absence of 6 µg/ml anti-Thy-1 mAb, anti-TcRβ mAb or an isotype control for the indicated times. Cell-free culture supernatants were collected and assayed for IL-2 using a commercially available ELISA kit. Data are expressed as the mean ± standard deviation of 3 independent experiments. * P<0.05, as indicated. BMDC, bone marrow-derived dendritic cell; Ig, immunoglobulin; IL, interleukin; mAb, monoclonal antibody; TcR, T cell receptor. Figure 3 . Thy-1 signaling is a less potent inducer of CD25 protein expression compared with TcR signaling. T cells with or without lipopolysaccharide-matured BMDCs were cultured in the presence or absence of 6 µg/ml anti-Thy-1 mAb, anti-TcRβ mAb or an isotype control for the indicated times. Only the 0 h T cell group was cultured without BMDCs. CD25 protein expression levels in cell lysates were assessed by western blot analysis. Blots were probed for β-actin as a loading control. The blot is a representative of 3 independent experiments. Data are expressed as the mean optical density ratio normalized to β-actin ± standard error of the mean of 3 independent experiments. * P<0.05, as indicated. Data at the 0 h time-point compares T cells plus BMDCs treated with hamster IgG vs. rat IgG. BMDC, bone marrow-derived dendritic cell; CD, cluster of differentiation; Ig, immunoglobulin; mAb, monoclonal antibody; TcR, T cell receptor.
Discussion
In the present study, the T cell-activating signal generated by crosslinking of Thy-1 by mAb via Fc receptors on syngeneic BMDCs and associated costimulatory signaling was revealed to be relatively weak and delayed compared with the signal generated by anti-TcRβ mAb-mediated stimulation under similar conditions. Therefore, at the maximal mitogenic concentration, anti-Thy-1 mAb was less potent in its ability to promote cyclin D3 expression, DNA synthesis, CD25 protein expression and IL-2 production, which are markers of T cell activation (30) , compared with the anti-TcRβ mAb. It was hypothesized that a greater number of Thy-1 molecules were crosslinked by mAb compared with TcRβ, as excess mAbs were used, and it has been reported that T cells express ~200,000 Thy-1 molecules/cell and only ~2,000 TcR molecules/cell (31, 32) . This serves to underscore the relative weakness of the activation signal delivered by Thy-1 compared with TcR, and argues that any minor differences in the affinity of each mAb for its target are unlikely to account for the observed effects. In addition, the expression of survivin was similar in anti-Thy-1 mAb-and anti-TcRβ mAb-stimulated T cells, which suggested that the activation of the signaling pathway controlling the expression of this antiapoptotic molecule was similar under both stimulation conditions. As the proliferation of activated T cells depends on the autocrine IL-2/IL-2 receptor system (29) , it may be that the weaker proliferative response of T cells to Thy-1 crosslinking compared with TcRβ crosslinking was a consequence of low IL-2 synthesis and/or CD25 expression. However, insufficient IL-2 production was not the only reason behind the weak lymphoproliferative response, as the addition of exogenous IL-2 did not enhance DNA synthesis in Thy-1-stimulated T cells.
ZAP-70 is crucial for TcR signaling (33) , and Thy-1-associated p85-90 contains a potential docking site for the Src homology 2 domain of ZAP-70 (15) . The ERK1/2 signaling pathway, which is downstream of TcR, also serves an important role in TcR-mediated T cell activation and survival (34, 35) , and in Thy-1-induced T cell proliferation and IL-2 production (11) . The present study revealed that the phosphorylation of ZAP-70 and ERK1/2 was delayed in Thy-1-stimulated T cells compared with T cells activated with TcRβ mAb, which may have contributed to the reduced IL-2 and CD25 expression and the subsequent suppression of DNA synthesis. Thy-1 and TcR signaling pathways involve the activation of protein tyrosine kinases (10, 36) . Phosphorylation of tyrosine residues in the immunoreceptor tyrosine-based activation motifs (ITAMs) of the TcR-associated ζ chain by Lck, and to a lesser extent by Fyn, was previously revealed to result in the recruitment and activation of ZAP-70 (33) . Therefore, the phosphorylation of ZAP-70 in response to Thy-1 crosslinking suggested a possible prior Lck-and/or Fyn-mediated phosphorylation of ζ chain ITAMs. Thy-1 is not physically associated with the TcR (16); however, Thy-1 co-localizes with Lck and Fyn in lipid rafts that aggregate in response to Thy-1 crosslinking (37) . Therefore, Thy-1 stimulation may bring Lck and Fyn molecules in close proximity with ζ chain ITAMs, which may result in the activation of downstream signaling molecules. The present study hypothesized that Thy-1 signaling may be weaker and has delayed kinetics compared with TcR signaling, owing to the poor accessibility of the ζ chain to Thy-1-aggregated Lck and Fyn.
The delayed kinetics of ZAP-70 and ERK1/2 phosphorylation following Thy-1 crosslinking led to the re-evaluation of our previous findings, which suggested that Thy-1-activated T cells may fail to function in 4 h cytotoxicity assays, even though these cells possess cytolytic granules and effector molecules (7) . Granule-mediated cytotoxicity, which is dependent on extracellular Ca 2+ and involves the exocytosis of granule-associated granzymes and perforin, and cytotoxicity mediated via the Fas/Fas ligand death-receptor pathway, which does not use extracellular Ca 2+ , are the two principal effector mechanisms of cytotoxic T lymphocytes (38) . The results of the present study suggested that, unlike granule-mediated T cell cytotoxicity induced by TcR crosslinking, Thy-1 stimulation resulted in the delayed induction of Ca 2+ -independent cytotoxic activity. These data suggested that Fas ligand-mediated pathways, rather than cytotoxic granule proteins, may be involved in Thy-1-induced T cell cytotoxicity. The present findings are consistent with a previous study that used the BAK CD8 + T cell line, which were stimulated with immobilized anti-CD3 or anti-Thy-1 mAb in the absence of costimulation (39) . Notably, weak TcR signaling was also previously reported to activate Fas ligand-mediated cytotoxicity, but not granule-dependent cytotoxicity in T cells (22) . As the mobilization of preformed Fas ligand from cytotoxic granules, rather than de novo synthesis, is favored by weak TcR signaling (23), it may be hypothesized that cytolytic granules may also be the source of the Fas ligand used by Thy-1-stimulated cytotoxic T cells, which possess cytoplasmic granules and express abundant mRNA transcripts coding for Fas ligand, perforin and granzyme B (7) .
The physiological ligand for T cell-associated Thy-1 within immune compartments has yet to be determined (1-3); however, the non-polymorphic region of Thy-1 contains an Arg-Gly-Asp-like integrin-binding motif of Arg-Leu-Asp (40) . Therefore, Thy-1 expression on activated endothelial cells may interact with α M β 2 , α X β 2 , and α V β 3 integrins, as well as CD97; in addition α V β 3 and Syndecan-4 are ligands for neuronal Thy-1, and Thy-1 expressed by activated fibroblasts binds α V β 5 -and β 2 -containing integrins (1) . As the mitogenic anti-Thy-1 mAb (clone G7) used in the present study binds to the non-polymorphic region of Thy-1 (41) , this mAb may interact with and crosslink a ligand-binding domain that triggers a signal similar to that induced by the physiological ligand. As Thy-1 may induce a non-specific TcR-like signal that promotes the development of Fas ligand-mediated cytotoxic effector function, it is suggested that the expression of the Thy-1 ligand in immune compartments may be strictly regulated to avoid potentially dangerous immunopathologies. However, the non-specific activation and proliferation of T cells in response to Thy-1 stimulation may serve a role in the clearance of intracellular pathogens that can subvert the development of antigen-specific immune responses (42) . Consistent with the involvement of Thy-1 in T cell-mediated immune responses, Thy-1-deficient mice were previously reported to exhibit diminished delayed-type hypersensitivity reactions (6) .
In conclusion, the present study demonstrated that mAb-mediated crosslinking of Thy-1, in the context of costimulation by BMDCs, provided mouse T cells with a TcR-like signal that was less potent and exhibited delayed kinetics compared with endogenous TcR signaling. In addition, Thy-1-activated T cells exhibited Ca 2+ -independent cytotoxicity in 24 h cytotoxicity assays, which is in accordance with previous reports that granule-mediated cytotoxicity may not be triggered by Thy-1 stimulation (7, 39) . The findings of the present study may serve to advance our understanding of the roles of Thy-1 in mouse T cell function.
